These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11143371)

  • 1. Bioceramics surface modification by means of osteoclasts in culture.
    Benghuzzi H; Puckett A; Tucci M; Roberts B
    Biomed Sci Instrum; 1999; 35():321-6. PubMed ID: 11143371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of HA, TCP and ALCAP bioceramic capsules on the viability of human monocyte and monocyte derived macrophages.
    Ross L; Benghuzzi H; Tucci M; Callender M; Cason Z; Spence L
    Biomed Sci Instrum; 1996; 32():71-9. PubMed ID: 8672693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological response associated with large particles of TCP, HA, and ALCAP implants using raw 264.7 cells.
    Thorns M; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():287-92. PubMed ID: 11347404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of various biomedical polymers concentration on the adhesion rate and viability of monocyte and monocyte derived macrophages.
    Benghuzzi HA
    Biomed Sci Instrum; 1995; 31():121-6. PubMed ID: 7654948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the cellular components of the fibrous tissue matrix surrounding ALCAP, HA, and TCP bioceramics using adult male rats as a model.
    Butler K; Puckett A; Benghuzzi H
    Biomed Sci Instrum; 1999; 35():267-72. PubMed ID: 11143360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical analysis associated with HL-60 cells incubated with various ceramic materials.
    Jones L; Tucci M; Benghuzzi H
    Biomed Sci Instrum; 1997; 34():53-8. PubMed ID: 9603012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical modifications of human macrophages treated with various biomaterials.
    Carr S; Johnston W; Benghuzzi H; Tucci M; Puckett A; Tsao A; Hughes J
    Biomed Sci Instrum; 1999; 35():211-6. PubMed ID: 11143349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological evaluation of the tissue-implant reaction associated with S/C and I/P implantation of ALCAP and HA bioceramics in vivo.
    Butler K; Benghuzzi H; Puckett A
    Pathol Res Pract; 2001; 197(1):29-39. PubMed ID: 11209814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric evaluation of tissue-implant reaction associated with ALCAP and TCP bioceramics in vivo.
    Butler KR; Benghuzzi HA; Puckett A
    J Invest Surg; 2001; 14(3):139-52. PubMed ID: 11453179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the effect of new bone formation on new type artificial bone composed of bioactive ceramics].
    Zhu M; Zeng Y; Sun T; Peng Q
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):174-7. PubMed ID: 15828468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of fibrous tissue formation surrounding intraperitoneal and subcutaneous implantation of ALCAP, HA, and TCP ceramic devices.
    Butler K; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 1997; 34():18-23. PubMed ID: 9603006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of TCP/HA-coating titanium on the adhesion behavior of human gingival fibroblasts].
    Zhao BH; Bai W; Feng HL; Cui FZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Nov; 39(6):501-4. PubMed ID: 15854325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro testing of calcium phosphate (HA, TCP, and biphasic HA-TCP) whiskers.
    Jalota S; Bhaduri SB; Tas AC
    J Biomed Mater Res A; 2006 Sep; 78(3):481-90. PubMed ID: 16721798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro release of azidothymidine (AZT) by ceramic drug delivery systems.
    Benghuzzi HA; Barbaro RM; Bajpai PK
    Biomed Sci Instrum; 1990; 26():151-6. PubMed ID: 2334759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biocompatibility of HA/TCP biphasic ceramics with co-cultured human osteoblasts in vitro].
    Lu X; Li S; Zhang J; Zhang Z; Lu B; Bu H; Li Y; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2001 Dec; 18(4):497-9. PubMed ID: 11791290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro degradation, bioactivity, and cytocompatibility of calcium silicate, dimagnesium silicate, and tricalcium phosphate bioceramics.
    Ni S; Chang J
    J Biomater Appl; 2009 Aug; 24(2):139-58. PubMed ID: 18801892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a model for bioresorbability of bioceramic microparticles.
    Bell L; Benghuzzi H; Tucci M; Cason Z
    Biomed Sci Instrum; 2001; 37():161-6. PubMed ID: 11347381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone ingrowth into two porous ceramics with different pore sizes: an experimental study.
    Galois L; Mainard D
    Acta Orthop Belg; 2004 Dec; 70(6):598-603. PubMed ID: 15669463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of Zn2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts.
    Yamada Y; Ito A; Kojima H; Sakane M; Miyakawa S; Uemura T; LeGeros RZ
    J Biomed Mater Res A; 2008 Feb; 84(2):344-52. PubMed ID: 17618520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Micro-particles of bioceramics could cause cell and tissue damage].
    Lu J; Tang T; Ding H; Dai K
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):85-9. PubMed ID: 16532817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.